Lanean...

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents

Immunotherapy has recently emerged as a novel strategy for treating different types of solid tumors, with promising results. However, still a large fraction of patients do not primarily respond to such approaches, and even responders sooner or later develop resistance. Moreover, immunotherapy is a p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Med
Egile Nagusiak: Ciciola, Paola, Cascetta, Priscilla, Bianco, Cataldo, Formisano, Luigi, Bianco, Roberto
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141336/
https://ncbi.nlm.nih.gov/pubmed/32138216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030675
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!